Honourable Speaker DR Anand Srivastava at 1ST INTERNATIONAL CONFERENCE ON MEDICINE AND RESEARCH (ICMR-21)

Topic : Role of Stem Cell in Covid-19

Dr. Srivastava is a Chairman and Cofounder of the California-based Global Institute of Stem Cell Therapy and Research (GIOSTAR) headquartered in San Diego, California (USA). Several governments and organizations – including the United States, India, China, Turkey, Kuwait, Thailand, Philippines, Bahamas, Saudi Arabia and many others seek his advice and guidance on drafting their strategic and national policy formulations and program directions in the area of stem cell research, development, and its regulations.

The company was formed with the vision to provide stem cell-based therapy to aid those suffering from degenerative or genetic diseases around the world such as Parkinson’s disease, Alzheimer’s disease, neuropathy, diabetes, heart disease, stroke, spinal cord injuries, paralysis, and blood related diseases. GIOSTAR is a leader in developing the most advanced stem cell-based technology, supported by leading scientists with pioneering publications in the area of stem cell biology. The company’s primary focus is to discover and develop a cure for human diseases, with state-of-the art, unique stem cell-based therapies and products. Regenerative medicine provides promise for treatments of diseases previously regarded as incurable.

Under Dr. Srivastava’s creative leadership, a group of esteemed scientists and clinicians are developing stem cell therapies for various types of autoimmune diseases and blood disorders.

Dr. Anand Srivastava has been associated with leading universities and research institutions throughout the world. In affiliation with University of California San Diego (UCSD) School of Medicine, University of California Irvine (UCI) School of Medicine, The Salk Institute for Biological Studies in San Diego, The Sanford Burnham Prebys Medical Discovery Institute, and University of California, Los Angeles (UCLA) School of Medicine, Dr. Srivastava has developed several research projects. He has extensive research experience in the field of stem cells, which is documented by several publications in revered scientific journals.

California, United States

Dr. ANAND Srivastava, MS

Posted in

Recent Blog

GIOSTAR: The Shining Star of Modern Healthcare Industry & BioTech
Giostar has agreed to commercialize and promote dcgi (Indian FDA) approved stem cell therapies for critical lab ischemia and osteoarthritis
Dr. Anand Srivastava, GIOSTAR Co-Founder: How Does Cell Therapy Work?

Latest News

Health Talk on Metabolic Diseases Can Be Cured by Stem Cell Therapy at USTM, Guwahati on Dec 18, 2021, by DR. Anand Srivastava Chairman GIOSTAR- USA.
SAASCR honours GIOSTAR chairman DR. Anand & 9 Indian American Scientists for their Outstanding Cancer Researching
Global Business Icons 2022 – Dr Anand Srivastava Chairman & CSO, GIOSTAR

Videos

Meet Dr. Anand Srivastava
Dr Anand Srivastava of GIOSTAR Discusses How Stem Cells and Regenerative Therapy Treat Diabetes
What is Stem Cell Therapy? by Dr. Anand Srivastava | 40th Vikram Sarabhai Memorial Lecture | GIOSTAR